The Quantum Biomedical Sensing (Q-BIOMED) Research Hub – the UK's first quantum hub for biomedicine – aims to deliver a step change in earlier disease diagnosis and treatment for diseases including cancer and Alzheimer’s disease.  

Earlier diagnosis, through ultra-sensitive blood tests, faster MRI scan times, and improved access through lower costs and portable instruments, could offer a paradigm shift in healthcare. 

These advances could enable much earlier diagnosis of disease such as cancer allowing for more rapid medical interventions and potentially saving lives. Ultimately, this could translate to better patient outcomes and help to reduce waiting lists, easing pressures on the NHS. 

The Q-BIOMED Hub is part of a £160M network of five new Quantum Technology Research Hubs, set up as part of the UK National Quantum Technology Programme, to ensure the UK benefits from the potential of quantum technologies.